Shanghai Pioneer Holding Ltd

SEHK:1345 Stock Report

Market Cap: HK$2.7b

Shanghai Pioneer Holding Past Earnings Performance

Past criteria checks 2/6

Shanghai Pioneer Holding has been growing earnings at an average annual rate of 23.4%, while the Healthcare industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 5.3% per year. Shanghai Pioneer Holding's return on equity is 12.8%, and it has net margins of 9.9%.

Key information

23.4%

Earnings growth rate

24.1%

EPS growth rate

Healthcare Industry Growth11.3%
Revenue growth rate5.3%
Return on equity12.8%
Net Margin9.9%
Last Earnings Update30 Jun 2024

Recent past performance updates

Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Apr 01
Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Recent updates

Shanghai Pioneer Holding Ltd (HKG:1345) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Dec 10
Shanghai Pioneer Holding Ltd (HKG:1345) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price

Jul 15
Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price

Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024

Apr 24
Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024

Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024

Apr 03
Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024

Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Apr 01
Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks

Mar 22
Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks

Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital

Feb 26
Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital

Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?

Oct 21
Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?

Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024

Sep 18
Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024

Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024

Sep 01
Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024

Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching

Aug 09
Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Apr 14
Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Mar 31
Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly

Dec 15
Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly

China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018

Sep 21
China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018

China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Sep 02
China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward

Jun 22
China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064

Apr 14
China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064

China Pioneer Pharma Holdings (HKG:1345) Will Be Hoping To Turn Its Returns On Capital Around

Jan 16
China Pioneer Pharma Holdings (HKG:1345) Will Be Hoping To Turn Its Returns On Capital Around

These 4 Measures Indicate That China Pioneer Pharma Holdings (HKG:1345) Is Using Debt Safely

Oct 11
These 4 Measures Indicate That China Pioneer Pharma Holdings (HKG:1345) Is Using Debt Safely

China Pioneer Pharma Holdings (HKG:1345) Is Paying Out Less In Dividends Than Last Year

Sep 15
China Pioneer Pharma Holdings (HKG:1345) Is Paying Out Less In Dividends Than Last Year

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.056

Sep 01
China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.056

China Pioneer Pharma Holdings (HKG:1345) Will Be Looking To Turn Around Its Returns

Aug 26
China Pioneer Pharma Holdings (HKG:1345) Will Be Looking To Turn Around Its Returns

Returns On Capital At China Pioneer Pharma Holdings (HKG:1345) Paint A Concerning Picture

May 22
Returns On Capital At China Pioneer Pharma Holdings (HKG:1345) Paint A Concerning Picture

We Think China Pioneer Pharma Holdings (HKG:1345) Can Stay On Top Of Its Debt

Apr 25
We Think China Pioneer Pharma Holdings (HKG:1345) Can Stay On Top Of Its Debt

Can Mixed Financials Have A Negative Impact on China Pioneer Pharma Holdings Limited's 's (HKG:1345) Current Price Momentum?

Mar 14
Can Mixed Financials Have A Negative Impact on China Pioneer Pharma Holdings Limited's 's (HKG:1345) Current Price Momentum?

How Has China Pioneer Pharma Holdings (HKG:1345) Allocated Its Capital?

Feb 21
How Has China Pioneer Pharma Holdings (HKG:1345) Allocated Its Capital?

Should You Use China Pioneer Pharma Holdings' (HKG:1345) Statutory Earnings To Analyse It?

Feb 03
Should You Use China Pioneer Pharma Holdings' (HKG:1345) Statutory Earnings To Analyse It?

Is China Pioneer Pharma Holdings Limited (HKG:1345) At Risk Of Cutting Its Dividend?

Jan 16
Is China Pioneer Pharma Holdings Limited (HKG:1345) At Risk Of Cutting Its Dividend?

China Pioneer Pharma Holdings (HKG:1345) Has A Rock Solid Balance Sheet

Dec 29
China Pioneer Pharma Holdings (HKG:1345) Has A Rock Solid Balance Sheet

Is China Pioneer Pharma Holdings Limited's (HKG:1345) Stock Price Struggling As A Result Of Its Mixed Financials?

Dec 14
Is China Pioneer Pharma Holdings Limited's (HKG:1345) Stock Price Struggling As A Result Of Its Mixed Financials?

China Pioneer Pharma Holdings (HKG:1345) Has Gifted Shareholders With A Fantastic 124% Total Return On Their Investment

Nov 29
China Pioneer Pharma Holdings (HKG:1345) Has Gifted Shareholders With A Fantastic 124% Total Return On Their Investment

Revenue & Expenses Breakdown

How Shanghai Pioneer Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:1345 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241,6481645212
31 Mar 241,6071555281
31 Dec 231,5671465350
30 Sep 231,6001685490
30 Jun 231,6341905640
31 Mar 231,5952135560
31 Dec 221,5562355480
30 Sep 221,4822165510
30 Jun 221,4081965550
31 Mar 221,4221695700
31 Dec 211,4351435850
30 Sep 211,4151175940
30 Jun 211,395916020
31 Mar 211,364725690
31 Dec 201,332525350
30 Sep 201,325455230
30 Jun 201,318375120
31 Mar 201,317715270
31 Dec 191,3161055410
30 Sep 191,304845310
30 Jun 191,293635210
31 Mar 191,459745020
31 Dec 181,624854830
30 Sep 181,8511714730
30 Jun 182,0772584630
31 Mar 182,1162694500
31 Dec 172,1542794370
30 Sep 172,0832794190
30 Jun 172,0122804010
31 Mar 171,9012593760
31 Dec 161,7902373510
30 Sep 161,6271742970
30 Jun 161,4641112430
31 Mar 161,4621432230
31 Dec 151,4611742020
30 Sep 151,5332312080
30 Jun 151,6052872130
31 Mar 151,5732742100
31 Dec 141,5402622080
30 Sep 141,5002621840
30 Jun 141,4602631610
31 Mar 141,3662501480

Quality Earnings: 1345 has high quality earnings.

Growing Profit Margin: 1345's current net profit margins (9.9%) are lower than last year (11.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 1345's earnings have grown significantly by 23.4% per year over the past 5 years.

Accelerating Growth: 1345's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 1345 had negative earnings growth (-13.9%) over the past year, making it difficult to compare to the Healthcare industry average (-16.9%).


Return on Equity

High ROE: 1345's Return on Equity (12.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 02:25
End of Day Share Price 2025/01/10 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Pioneer Holding Ltd is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo LiBOCOM International Securities Limited
Kenneth LiCinda International Research Limited
Sze Chuen TamCore Pacific -Yamaichi International (H.K.) Limited